| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |